The impact of an educational and information systems initiative on somatic BRCA testing rates in patients with high grade serous tubo-ovarian cancer in Western Australia

The impact of an educational and information systems initiative on somatic BRCA testing rates in patients with high grade serous tubo-ovarian cancer in Western Australia

Objective: Poly-ADP ribose polymerase inhibitors (PARPi) have expanded the management armamentarium against high grade serous tubo-ovarian cancer (HGSOC) in patients with germline and somatic BRCA pathogenic variants (PVs). Germline testing has been available in Western Australia (WA) since July 201...

Full description

Bibliographic Details
Main Authors: Andrew Fantoni, Tarek Meniawy, Paul A. Cohen, Michelle McMullen
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:Gynecologic Oncology Reports
Subjects:
High grade serous ovarian cancer
BRCA testing
PARP inhibitor
Genetics
Mainstreaming
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578923001157

Internet

http://www.sciencedirect.com/science/article/pii/S2352578923001157

Similar Items